Hip Replacement Devices Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product Type, By End User, By Region & Competition, 2021-2031F

The Global market for hip replacement devices is anticipated to expand from USD 6.11 billion in 2025 to USD 7.73 billion by 2031, reflecting a compound annual growth rate (CAGR) of 4.0%. These devices are specialized medical implants designed to relieve pain and restore functionality to hip joints that have been severely compromised by acute trauma, rheumatoid arthritis, or osteoarthritis. Market growth is primarily fueled by a worldwide increase in the aging population, a demographic naturally more susceptible to degenerative joint diseases, as well as the rising global rates of osteoarthritis. Additionally, ongoing innovations in surgical methodologies and implant materials are driving the market forward by enhancing device durability and patient recovery. The 2025 Annual Report from the American Academy of Orthopaedic Surgeons' American Joint Replacement Registry highlights this demand, noting the analysis of more than 4.4 million total knee and hip arthroplasties conducted in the United States using data gathered through 2024.

Conversely, the substantial costs tied to surgical procedures and the hip replacement implants themselves continue to be a major obstacle to global market growth. Such heavy financial burdens can severely limit patient accessibility, especially in areas characterized by restrictive reimbursement frameworks or underdeveloped healthcare systems, consequently hindering broader market adoption.

Market Driver

The expanding elderly population is a major catalyst for the global hip replacement devices market, as it broadens the demographic most vulnerable to age-induced joint deterioration. With rising life expectancies, the accumulated stress on joints-especially the hips-increasingly requires surgical restoration, directly resulting in a larger pool of prospective candidates for hip replacement procedures. The United Nations Department of Economic and Social Affairs' Population Division highlighted this trend in its "World Population Prospects 2024," noting that global life expectancy at birth hit 73.3 years in 2024. This growing longevity directly boosts the demand for medical interventions that preserve the independence and mobility of senior citizens.

Furthermore, the escalating rates of degenerative joint disorders like osteoarthritis serve as a fundamental market driver, given that they are the primary reasons for undergoing hip replacement. Sedentary habits and rising obesity levels are accelerating both the development and worsening of these disabling conditions, thereby driving up the need for successful treatments like hip arthroplasty. A December 2025 study titled "Global, regional, and national burden of osteoarthritis among middle-aged and older adults" estimated that 453.56 million older people worldwide suffered from osteoarthritis in 2021. This massive patient base highlights a sustained demand for cutting-edge hip replacement solutions, a trend further reflected in Stryker's Q4 2025 earnings report, which posted USD 9.5 billion in full-year orthopedic net sales for 2025.

Market Challenge

The steep expenses linked to complex surgical procedures and the hip replacement implants themselves present a major hurdle to the expansion of the global market. These high costs hinder patient accessibility, uniquely impacting areas with strict reimbursement rules or inadequate healthcare systems, which ultimately restrains broader market reach. The economic strain is not limited to simply purchasing the implant; it covers the full surgical process and the post-operative rehabilitation required. Consequently, this widespread financial obstacle can discourage suitable candidates from seeking essential treatments, despite suffering from significant functional limitations and severe pain caused by ailments such as osteoarthritis.

A 2023 survey conducted by the American Medical Association revealed that 78% of physicians reported prior authorization delays-a common tactic for controlling costs-caused their patients to abandon necessary medical treatments, including those related to hip arthroplasty. This frequent avoidance of care due to financial and administrative hurdles directly decreases the potential number of surgeries executed. As a result, it diminishes the size of the reachable patient demographic, thereby constraining the overall growth of the global hip replacement devices market.

Market Trends

A major trend transforming the global hip replacement devices market is the incorporation of computer-assisted and robotic surgical technologies. These sophisticated systems offer surgeons superior control and accuracy compared to conventional manual methods. By facilitating precise pre-surgical planning tailored to individual anatomy and delivering live guidance throughout the operation, these innovations seek to improve recovery times and perfect implant placement. Demonstrating this widespread adoption, Stryker's internal records show that more than 2 million Mako orthopedic procedures were executed globally through 2025. Ultimately, the desire for fewer complications and more reliable surgical results is driving this technological evolution.

An equally important trend is the escalating need for 3D-printed, patient-specific implants. This method allows for the manufacturing of bespoke devices that perfectly align with a patient's distinct anatomy, solving the fit issues sometimes associated with generic implants. Custom-made implants provide a superior fit that can enhance joint functionality, minimize component wear, and extend the overall lifespan of the device. Producing implants explicitly suited to individual requirements encourages more dependable outcomes, particularly in complicated surgeries. Highlighting this shift toward personalized hip arthroplasty, Materialise's Fourth Quarter and Full Year 2025 Results, released on February 18, 2026, reported that their customized solutions treated upwards of 17,000 patients in 2025 alone. This underscores the growing reliance on additive manufacturing to achieve better functional results in joint replacement.

Key Market Players

• Johnson & Johnson
• B. Braun Melsungen AG
• Stryker Corporation
• Zimmer Biomet Holdings Inc
• Corin Group
• Waldemar LINK GmbH & Co. KG
• MicroPort Scientific Corporation
• Exactech Inc.
• Conformis Inc.
• OMNIlife Science Inc

Report Scope

In this report, the Global Hip Replacement Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hip Replacement Devices Market , By Product Type

• Primary Hip Reconstruction Devices
• Partial Hip Reconstruction Devices
• Revision Hip Reconstruction Devices
• Hip Resurfacing Devices

Hip Replacement Devices Market , By End User

• Hospitals
• Ambulatory Care Centers
• Orthopedics Clinics
• Others

Hip Replacement Devices Market , By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hip Replacement Devices Market .

Available Customizations:

Global Hip Replacement Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).